MS-N328 · Mindful breathing · Symptom cluster · Advanced cancer · Human evidence · Appraised 13 November 2026

Do four daily 30-minute mindful-breathing sessions rapidly reduce multiple symptoms in adults with advanced cancer?

Evidence at a glance

• Evidence label: Small randomized study; short-term within-session symptom reductions, between-group magnitude incompletely reported
• Benefit: Total symptom scores fell after all four breathing sessions, but control scores also improved after some sessions.
• Certainty: Low because the report emphasizes within-group tests, short-term changes and one center.
• Risk: No adverse-event summary was verified. Breathlessness, pain or rapid deterioration still require medical assessment.

What was studied

Eighty adults with advanced cancer and at least two Edmonton Symptom Assessment Scale symptoms rated 4 or higher were randomized equally to four consecutive daily 30-minute mindful-breathing sessions plus standard care or standard care alone.

What the evidence found

Total ESAS scores improved significantly after each of the four sessions in the breathing group. The control group also showed significant reductions after sessions one and three. The abstract did not provide the between-group absolute difference, confidence interval or a responder threshold, which limits causal and clinical interpretation.

How to interpret it

The trial recruited over a short 2020 period at one Malaysian center. Immediate self-reported symptom change does not establish durable relief, reduced medication use, hospitalization, survival or tumor control. The registration date was later than recruitment, which should be considered when evaluating outcome selection.

These outcomes concern symptoms, distress, sleep or supportive care. They do not establish tumor response, delayed recurrence, progression-free survival or longer overall survival.

Practical safety context

Mindful breathing may help settle attention, but it does not identify the cause of breathlessness or pain. New chest pain, low oxygen, confusion, fever, bleeding or rapidly worsening symptoms require urgent evaluation. Some people with panic or trauma may prefer shorter, eyes-open practice with a clinician.

Questions for the care team

• Which symptoms are safe to address with breathing and which need diagnostic work-up?
• Was the trial’s short-term change large enough to matter clinically?
• Who will modify or stop the practice if I become dizzy, panicked or more breathless?

Funding and conflicts

The study was supported by a UNIMAS Cross Discipline Research Grant; the authors declared no competing interests.

Sources

• Primary trial (PMID 39965903)
• Publisher record and DOI 10.1136/spcare-2024-005086
• ClinicalTrials.gov NCT05910541

Last literature search: 13 November 2026. Record appraisal: 13 November 2026. The primary report and abstract were appraised; registry timing is retained as a limitation. This page is educational and does not replace individualized medical advice.